Introduction
Transcriptional regulation is dependent upon interactions between nuclear proteins. Protein ± protein interactions are involved in every step of cell signaling, including receiving of signal, selection of target genes, regulation of DNA binding ability, regulation of transcriptional activity and turn-over of transcription factors. Ets proteins are a family of transcription factors which play roles in important biological processes, including cellular proliferation, dierentiation, development, transformation, immune response and apoptosis. (Bhat et al., 1996; Ghysdael and Boureux, 1997; Graves and Petersen, 1998; Watson et al., 2001) : Structural analyses have demonstrated that most Ets proteins bind DNA as monomers (Kodandapani et al., 1996; Liang et al., 1994; Werner et al., 1995) , unlike many other well-known families of transcription factors that can bind DNA as homo-or heterodimers. The transcriptional activity of Ets proteins is modulated by other factors/partners (Bhat and Papas, 1994; Crepieux et al., 1994) . Functional interaction between Ets proteins and other factors have been observed and plays an important role in many biological processes. However, many physical interactions cannot be demonstrated by direct binding assays due to the weak anity, transient binding or absence of required cofactors, such as DNA or a third partner. In recent years, based on the improved technologies, such as two hybrid interactive screens, many novel proteins have been identi®ed as Ets family partners. Evaluation of the physical interaction and correlation with function has greatly advanced our knowledge on regulation of eukaryotic gene transcription. The network of Ets control is emerging from the studies of Ets interacting proteins. This review will examine some of the protein ± protein interactions that have been identi®ed and describe speci®c examples that establish correlation between Ets interacting partners and speci®c biological functions.
Regulation of DNA binding ability
DNA binding ability is the key property of all transcription factors. The modulation of DNA binding can be viewed as the ®rst level of transcriptional control. Although most of Ets proteins bind to DNA as monomers, DNA binding activity is enhanced or modulated by other factors. The identi®ed intramolecular regulatory regions have been localized to conserved domains found in most Ets family members . DNA binding can be increased by the removal of negative regulatory domains, such as exon VII of Ets1 (Fisher et al., 1994) . Interacting proteins also can relieve the intramolecular inhibition of DNA binding capacity. Interaction of SRF with the carboxy-terminal region of the ETS domain of Elk1 increases its ability to bind to a subconsensus DNA binding site (Rao and Reddy, 1992) . Similarly, formation of Ets1-CBF-DNA complexes increases the anity of Ets1-DNA interactions and decreases the rate of dissociation of CBF from the TcR a and b enhancers, resulting in synergistic activation (Wotton et al., 1994) . Exon VII of Ets1 and NRDB of PEBP2aB/AML1/ CBFa2 are negative regulative domains. Direct interaction of these two regions leads to an increase of DNA binding anity and subsequent transcription activity by both partners (Kim et al., 1999) . The dynamic balance of the interaction between CBFa2 and either of its two alternative partners, Ets1 or CBFb, is one example of combinatorial control of transcriptional regulation (Gu et al., 2000) . The paired box transcription factor Pax-5 stabilizes the DNA binding of Ets1, as well as PU.1, Elk-1 and Net to the mb-1 promoter. Both Pax-5 and Ets binding sites are necessary for ternary complex formation (Fitzsimmons et al., 1996) . It has been recently demonstrated that the amino-terminal sub-domains of Pax speci®cally interact with the DNA binding (ETS) domain of Ets1 and the ability to recruit Ets proteins to bind Pax/EBS (Ets Binding Site) composite site is a property of multiple Pax proteins (Wheat et al., 1999) . The bHLH zipper proteins, TFE3 and USF, also enhance binding of Ets proteins to EBS by relieving the intramolecular inhibition via direct protein ± protein association (Tian et al., 1999) .
Target gene selection
Functional transcription is often dependent upon the selection of suboptimal nucleotide sequence(s) present in the target gene. The lineage-speci®c and inducible expression of eukaryotic genes is controlled by assembly of multipartite complex of transcription factors on regulatory regions composed of sequencespeci®c protein binding sites. Protein ± protein interactions direct Ets family members and other transcriptional factors to act on promoters/enhancers to increase transcription of Ets target genes. Physical interaction of Ets1 with GHF-1 is required for establishing lactotroph-speci®c PRL gene expression (Bradford et al., 1995) . The Ets1-GHF-1 synergy requires a composite Ets1-GHF-1 cis-element, which exist only in the PRL promoter but not in GH promoter (Bradford et al., 1997) . This synergy is one of the mechanisms by which dierent cell or tissue speci®c responses to identical signals is controlled. Several examples demonstrate that tissue-speci®c gene expression is achieved via the combinations of speci®c sets of transcription factors unique to each cell lineage or stage of dierentiation. The interaction of Ets1 with tissue-restricted PEBP2aB/AML1 leads to a contextdependent transcription regulation (Kim et al., 1999) . Pip (interferon regulatory factor) binds to its appropriate DNA element only in the presence of PU.1 (Eisenbeis et al., 1995) . Phosphorylated PU.1 recruits Pip to form a ternary complex with speci®c EBS/Pip sequences in the promoter region of the Ig k light chain gene (Brass et al., 1996; Ortiz et al., 1999; Perkel and Atchison, 1998) . This speci®c combination of transcription factors coordinates protein ± protein and protein-DNA interactions and confers cell type speci®city to cytokine signals. Complexes formed between either Ets1 or Ets2 and Stat5 in response to IL-2 in T lymphocytes may control gene expression via binding to interferon g activated site (GAS) motifs (Rameil et al., 2000) . Functional cooperation can also be found among Stat1 and PU.1 on the FcgRI promoter in response to glucocorticoid stimulation (Aittomaki et al., 2000) . It is known that the transcriptional activity of Tax1 on the HTLV-I LTR is modulated by the cooperative interactions between NFkB, Ets1 and Tax1 (Gitlin et al., 1993; Seeler et al., 1993) . The Tax/Ets1 cooperative eect on the PTHrP P2 promoter is based on the ability of Tax, Ets1, and Sp1 to form a quaternary complex on the template DNA. Tax facilitates the interaction of Ets1 and Sp1 and participates directly in the transcription initiation process (Dittmer et al., 1997) Ternary complex formation Ets proteins are targets for phosphorylation in response to stimulation mediated through receptors, including, growth factor receptors, and integrin signaling. Ets proteins, like other transcription factors, associate with other proteins to form ternary complexes with DNA, thereby selecting the relevant target gene in a particular cell type. Three ternary complexes factors (TCFs), Elk1, Sap1a, and Net/ Sap2 were originally identi®ed (Wasylyk et al., 1998 ; see article in this issue by Yordy and MuiseHelmericks). The regulation of TCFs activity is an important mechanism by which the serum response element responds to growth factor signals (Treisman, 1994) . The TCF subfamily of Ets transcription factors are conserved from Drosophila to human and represent key nuclear targets of MAP kinase pathways. A well-known example of such an interaction involves the regulation of the c-fos gene, where ELK1 forms a ternary complex with SRF and the SRE motif present in the promoter. This is an example of the fundamental importance of protooncogene cooperation in cellular growth control (Hipskind et al., 1991) . The B-box of Elk-1 is both necessary and sucient to mediate protein ± protein interaction with SRF in the absence of the SRE (Shore and Sharrocks, 1994) . In TCFs, the ETS domain is amino terminal and linked by a¯exible spacer region to the SRF interacting region B-box (Janknecht et al., 1994; Ling et al., 1997; . In response to MAP kinase signaling, the B-box of Elk-1 forms an inducible a-helix and provides a surface to interact with SRF, which augments the DNA binding ability of Elk-1 (Ling et al., 1997) . Although able to bind the fos SRE, Delta Elk1, a variant of Elk-1 lacking the negative regulatory DNA binding domain (NRD), is unable to form a SRF dependent ternary complex with SRE and consequently cannot activate fos transcription (Rao and Reddy, 1993) . It has also been demonstrated that Fli1 and EWS/Fli1 can function as TCFs, forming ternary complexes with SRF on Erg1 (Watson et al., 1997) and c-fos (Dalgleish and Sharrocks, 2000; Watson et al., 1997) SREs. In addition to the response to serum or MAP kinase signaling, an indirect interaction between Fli1 and RAR alpha has been demonstrated. In response to retinoic acid, these partners repress one another through an unknown`bridging' factor (Darby et al., 1997) .
Cooperation with other transcription factors
Sequences¯anking the EBS not only partially de®ne individual family member binding speci®city, but also contains potential elements which may coordinate diverse cellular processes or mediate the cross-talk of dierent transduction pathways. Many transcription factors have their DNA binding sites adjacent to EBS. Depending on the precise sequence context, binding of Ets proteins near other transcription factors results in higher anity interaction, synergistic repression or activation of speci®c target genes. Combinatorial control of transcriptional regulation is dependent upon the interactions between multiple nuclear proteins. Cooperation among Ets family members and other transcriptional factors has been demonstrated by inferred transcription of a large number of enhancer or promoter elements containing overlapping controlling elements.
Ets/AP-1 AP-1 is a transcription factor consisting of jun/fos family proteins and plays an important role in the signaling response to an incredible array of stimuli (Wisdom, 1999) . Adjacent Ets and AP-1 binding sites occur in a large number of promoter/enhancer elements (Wasylyk et al., 1993; Westermarck and Kahari, 1999) and functional cooperation between Ets and AP-1 is critical for controlled expression of many genes, including cytokines (Gottschalk et al., 1993; Wang et al., 1994) , MMPs (Crawford and Matrisian, 1996; Gutman and Wasylyk, 1990; Jayaraman et al., 1999) , glutathione S-transferase (GST) Ya (Bergelson and Daniel, 1994; Crawford and Matrisian, 1996) , viral genes (Nothias et al., 1993; Wasylyk et al., 1990) , etc. The physical association between the DNA binding domain of Ets family proteins and AP-1 was demonstrated both in vitro and in vivo in activated human T cells (Bassuk and Leiden, 1995) . Interaction of c-Jun with Elf1 results in formation of either a trimolecular complex or an Ets-AP1-DNA ternary complex after recruitment of c-Fos protein. Correlation between physical interaction of Ets1 with AP-1 and cooperative transcriptional activity was demonstrated using a c-Jun/ c-Fos chimera protein, which is unable to interact with Ets proteins. GATA competes with c-Jun for binding to the b3/b4 site of PU.1 (ETS domain) and subsequently represses PU.1 transcriptional activity, indicating that the interaction between PU.1 and c-Jun is functionally important during hematopoietic cell dierentiation . Although other Ets proteins (Elf and Fli1) have been shown to interact with Jun via the ETS domain, the functional signi®cance of these interactions were not demonstrated (Bassuk and Leiden, 1995) . The expression of MMP genes are enhanced by a cooperative transcriptional activation between Ets1 and AP-1. It is interesting to note that synergistic transcriptional activation of tissue inhibitor of MMP (TIMP-1) can also be enhanced by the interaction between Ets1 and AP-1 (Logan et al., 1996) .
Ets/NFkB NFkB is a ubiquitous transcription factor involved in immune, in¯ammatory and stress responses (Gilmore, 1999) . Adjacent or overlapping binding sites for Ets and NFkB are present in many inducible lymphoid genes, including IL-2, IL2-receptor (John et al., 1995) , IL-3 (Gottschalk et al., 1993) , GM-CSF (Thomas et al., 1997) , IL-12 (Gri et al., 1998) , viral genes including the HIV-I enhancer (Seth et al., 1993) and signaling molecules, such as protein kinase CK2a (Krehan et al., 2000) . Co-transfection of NFkB and Ets contributes to synergistic transcription activation of HIV-I and HIV-II , GM-CSF (Thomas et al., 1997) , IL-2Ra (John et al., 1995) and IL-12 (Gri et al., 1998) . These functional cooperations require the physical interaction between NFkB and Ets protein and other factors as well. Elf1 physically associates with the p50 subunit of NFkB and c-Rel/ p65 in vitro, and the interaction between HMG-1Y and Elf1 may further stabilize the complex of Elf1/NFkB/ HMG-1Y. (John et al., 1995) . Leiden's laboratory has demonstrated that physical interaction between multiple Ets proteins (Ets1, Elf1 and PU.1) and NFkB are required for transactivation of HIV-I and HIV-II. The ETS domain of Ets1 is essential and sucient for interacting with HD region of p50 subunit of NFkB, but not p65 Ets/bZIP factors Crystal structures of basic leucine zipper (bZIP) factors demonstrate that the basic region of bZIP factors mediates protein ± DNA interaction, while the leucine zipper domain contributes to protein ± protein interactions (Glover and Harrison, 1995) . The coordination between two classes of transcription factors, Ets and bZIP, often plays a role in the expression of in¯ammatory response genes. The interaction between the ETS domain of PU.1 and the bZIP region of NF-IL6b results in the synergistic transcriptional activation of an arti®cial promoter containing both EBS and NF-IL6b consensus elements (Nagulapalli et al., 1995) . However, the transcriptional activity of NF-IL6 was observed on the IL1b core promoter, in the absence of a DNA binding site for NF-IL6. It is believed that NF-IL6 is tethered by PU.1 to achieve transcriptional activation, designated protein-tethered transactivation (PTT) (Yang et al., 2000) . PU.1 also tethers the bZIP transcription factor c-Jun, via interacting of ETS domain of PU.1 with basic domain of Jun, to enhance the transcriptional activity of the promoter of the M-CSF receptor gene . Furthermore, the Cytomegalovirus IE2 protein is tethered to PU.1 for activation of IL1b gene transcription . The Epstein-Barr virus (EBV) nuclear antigen 3C protein (EBNA-3C) activates the LMP-1 promoter via interaction with PU.1 (Zhao and Sample, 2000) . Thus, PTT is a mechanism by which Ets function can be extended by the combination with cell-speci®c transcription factors under de®ned conditions. Ets/bHLH factors The basic helix ± loop ± helix (bHLH) transcription factors form homo-or heterodimers through their bHLH domains, enabling the basic regions to form a bipartite DNA-binding motif that recognize`E-box', and play a crucial role in controlling of speci®c developmental processes (Murre et al., 1994) . Although Ets-HLH synergistic activation was demonstrated previously (Rivera et al., 1993) , physical interactions between bHLH transcription factors and Ets proteins has recently been proven. USF-1 interacts with the ETS domain of Ets1 via its HLH domain resulting in cooperative activation of HIV-1 expression. In contrast, several other Ets family members, including Elf1 and PU.1, do not interact with USF-1 (Sieweke et al., 1998) . The consensus site of USF-1 and the TAD (Transactivation Domain) of Ets1 are essential for this activation of HIV-1. The binding of Ets1 in the absence of an EBS is another example of protein-tethered transactivation (PTT). The transcriptional synergy between the bHLH proteins E47 and TFE3 is dependent upon Ets1-mediated three protein-DNA complexes on the immunoglobulin m heavy-chain gene enhancer (Dang et al., 1998) . The NID (Net inhibitory domain) of Net/SAP2, a member of the TCF subfamily, interacts with the bHLH protein E47 through its HLH-like domain. This interaction is believed to change the conformation of Net/SAP2 and subsequently increased DNA binding .
Ets/Rb
Elf1 protein contains a motif that is highly related to the Rb binding sites of several viral oncoproteins and binds to the pocket region of Rb both in vitro and in vivo. Elf1 binds preferentially to unphosphorylated Rb and the phosphorylation of Rb results in the release of Elf1, which is correlated temporally with the activation of Elf1-mediated transcription . It is known that the pocket region of Rb interacts with many cell-cyclecontrol proteins such as cyclins and transcription factors (e.g., E2F, AP-1). The interaction between Rb and Ets may be important for the coordination of lineage-speci®c processes such as lymphokine production and lymphocyte activation. The Rb pocket domain, which is the binding site for the general transcription factor TFIID, can also bind to the Nterminus of PU.1, (Hagemeier et al., 1993) . Recently, it has been demonstrated that GOOSECOID protein (GSC), a homoebox gene product, interacts with PU.1 via its N-terminal portion, which is also the binding site of Rb. Thus, GSC competitively inhibits the binding of Rb to PU.1, resulting in the suppression of blood formation in early embryogenesis (Konishi et al., 1999) .
Since the ETS domain is highly conserved among all Ets family members, it is expected that several Ets family members may function on one gene simultaneously and the precise regulation of expression is achieved by this competition within the family. For example, synergistic transcription activation of MMP1 can be achieved by the interaction between ERG and AP-1 while ERG represses the transcriptional activation of MMP-1 by Ets2. This repression is dependent upon the physical interaction between ERG and Ets2 (Buttice et al., 1996; Basuyaux et al., 1997) .
Co-factor
CBP/p300 is an adapter protein, bridging many speci®c transcriptional factors with components of the basal transcriptional machinery such as TFIID (Janknecht and Hunter, 1996) . Both Ets1 and Ets2 recruit CBP/ p300 to active the MMP promoter (Jayaraman et al., 1999; Watabe et al., 1998) . Ets1 and CBP/p300 form a stable complex in a DNA independent manner and this complex possesses histone acetyltransferases (HAT) activity (Yang et al., 1998) . Since CBP/p300 interacts with many transcription factors, the precise biological outcome is dependent upon on its partner. Interaction with histone deacetyltransferases (HDAC) provides a mechanism by which the partner of Ets can serve as a co-repressor, leading to transcriptional silencing. Interaction between CtBP and NET provides a bridge between NET and HDAC1 (Criqui-Filipe et al., 1999), leading to transcriptional repression. Similarly, it is known that Rb, which interacts with Elf1, physically interacts with histone deacetylase HDAC1 (MagnaghiJaulin et al., 1998). Another example is Sp1, which interacts with many Ets factors (Block et al., 1996; Dittmer et al., 1997; Eichbaum et al., 1997; Krehan et al., 2000) ), and has been shown to interact with HDAC1 (Doetzlhofer et al., 1999) , repressing transcription. TEL is able to recruit co-repressors such as SMRT and mSin3A resulting in transcriptional repression Fenrick et al., 1999) .
Conversion of activator to repressor
The mechanisms that control transcription factor switching between activator and repressor remain to be determined. However, interaction between Ets and other transcription factors results in either activation or repression of speci®c target genes. The factors that determine whether an individual Ets factor functions as an activator or repressor include composition of DNA sequence, presence of tissue speci®c factors, alternative splicing and the combinatorial control by multiple transcription factors. In contrast to the synergistic activation via the EBS/AP-1 elements present in the MMP1 and MMP3 promoters, binding of Ets proteins near the EBS/AP-1 of the polyoma virus enhancer represses AP-1 transcriptional activation (Goldberg et al., 1994) . MafB, an AP-1 like protein, interacts with Ets1 in a DNA-dependent manner and inhibits Ets1-mediated transactivation of the transferrin receptor gene. This interaction inhibits erythroid dierentiation (Sieweke et al., 1996) . PU.1 also functions as a repressor by interacting with GATA-1, a zinc ®nger transcription factor required for erythroid dierentiation. Both DNA binding and activation domains of PU.1 are required for inhibition of GATA-1-dependent transcription. The interaction between PU.1 and GATA-1 does not depend on the presence of consensus DNA sequences. GATA-1 seems not to aect DNA binding or transcriptional function of PU.1 (Rekhtman et al., 1999) . GATA-1 also is a repressor of PU.1 function. A possible mechanism for this repression is competition between c-Jun and GATA-1 for interaction with the ETS domain of PU.1 . In myeloid cells, GATA-1 represses myeloid gene expression, at least in part, through its ability to directly interact with the ETS domain of PU.1 and thereby interfere with PU.1 function (Nerlov et al., 2000) . Transformation activity or cancer progression has been linked with the alteration of the Pointed domain. Substitution of the Pointed domains of ERG and Fli1 by EWS in the chimeric EWS-ERG and EWS-Fli1 results in strong transforming factor (Bailly et al., 1994; May et al., 1993) . This may be in part due to ability of EWS-Fli1, but not Fli1, to interact with human RNA polymerase II (hsRPB7). HsRPB7 has characteristics of a regulatory subunit of RNA polymerase II and may in¯uence promoter selectivity (Petermann et al., 1998) . In contrast, the leukemiaassociated t(12 : 21) translocation generates the TelAML1b chimeric protein. In this protein, gain of the Pointed domain converts AML1b from an activator to a repressor of transcription (Hiebert et al., 1996) . These observations indicate that the Pointed domain may represent a specialized protein ± protein interaction interface which is likely to be an important determinant of their speci®city as transcriptional regulators though other partner (Fenrick et al., 1999 
and article by Mavrothalassitis and Ghysdael in this issue).
We have recently demonstrated that Ets1 interacts with the Daxx protein, referred to as EAP1 (Ets1 Associated Protein 1) and the interaction of EAP1/ Daxx with Ets1 causes the repression of transcriptional activation of model target genes (MMP1 and Bcl2) (Li et al., 2000) . It remains to be determined whether Daxx/EAPI serves as a common co-repressor for additional Ets family members as well as for other transcription factors. The HLH protein Id2 interacts with either Elk-1 or SAP1 and disrupts ternary complex formation between Elk-1 or Sap1 at the cfos SRE, blocking the cellular response to MEK . ELK1 forms a ternary complex with SRF protein and the SRE motif present in the c-fos promoter (Hipskind et al., 1991) . In most TCFs, the ETS domain is amino terminal and linked by a¯exible spacer region to the SRF interaction domain (Janknecht et al., 1994; Ling et al., 1997; Shore and Sharrocks, 1994) . (b) Intramolecular inhibition of Ets proteins can be abolished through speci®c protein interaction. bHLH proteins are common proteins which interact with both the inhibitory and ETS domain, resulting in removal of the intramolecular inhibition and increased DNA binding ability of Ets protein, respectively Petersen et al., 1995; Tian et al., 1999) . (c) The Pointed domain is found in a subset Ets family members and mediates proteinprotein interaction between Ets family members allowing formation of homo-or hetero-dimers. This dimerization may block transcription or allow constitutive signalling (Fears et al., 1997; Hiebert et al., 1996; Jousset et al., 1997) . (d) The stable interaction between two proteins having distal DNA binding sites (Ets1 and CREB) requires a third protein (CBF). Structural alterations, such as the DNA bending via LEF1, can further stabilize macromolecular complexes, leading to synergistic activation on enhancer TCRa (Giese et al., 1995; Mayall et al., 1997) and HIV-1 (Sheridan et al., 1995) . (e) Protein-tethered transactivation (PTT). Transcription factors may function in genes that do not have the required DNA binding site in the promoter region. Binding of one transcription factor serves as a tether for another transcription factor. Wara-aswapati et al., 1999; Yang et al., 2000; Zhao and Sample, 2000) . (f) Ets interacting partner may bridge or block the cooperation between an Ets factor and the basal transcriptional machinery (Jayaraman et al., 1999; Yang et al., 1998) signals (Yates et al., 1999) . Similarly, ERF (Ets2 Repressor Factor) can disrupt the cooperative interactions between Pit-1 and Ets1, blocking Pit-1-dependent prolactin promoter activity in response to cAMP signals (Day et al., 1998) .
Hetero-or homo-dimerization
Most of Ets protein bind to DNA as monomer. The only example of Ets protein binding to DNA as a hetero-dimer is the transcription factor GA-binding protein (GABPab) (LaMarco et al., 1991; . GABPab is composed of two subunits, GABPa and GABPb. GABPa, contains the ETS domain and GABPb contains the transactivation domain (TAD) and the ankyrin repeats (Brown and McKnight, 1992; LaMarco et al., 1991; . The transcriptional activity of GABPa is dependent upon its heterodimerization with GABPb and the DNA binding anity of GABPa can be greatly enhanced by this heterodimerization (Gugneja et al., 1995) . However, the heterodimer of GABPa with GABPg is unable to active transcription even though GABPg is able to enhance GABPa DNA binding (Sawada et al., 1994; Suzuki et al., 1998) . The ratio of GABPb to GABPg may thus control GABP heterodimer-dependent transcription in a tissue speci®c manner (Suzuki et al., 1998) . Homo-dimerization within the Ets family involves the Pointed/HLH domain. The Pointed domain, the second conserved domain in a subset of Ets family proteins, possesses an independent structure with unique architecture of a monomeric ®ve-helix bundle (Slupsky et al., 1998) . The dimerization via Pointed domain of aberrant fusion proteins lead to a permanent signal activity in signaling transduction, which are characteristic of the leukemic cells (Ghysdael and Golub et al., 1994; Ho et al., 1999; Jousset et al., 1997; Lacronique et al., 1997; Papadopoulos et al., 1995; Peeters et al., 1997; Romana et al., 1995) . The isoforms of ERG, a Pointed domain containing Ets family member, form homodimers with itself or hetero-dimers with some other Ets proteins including Fli-1, Ets2, Er81 and PU.1 via Pointed domain and/or ETS domain (Carrere et al., 1998) . Recently, Drewett and his colleague have shown that the formation of inducible dimerization of Elk-1 may be the mechanism by which the MAP kinase signal are transferred to the transcriptional control (Drewett et al., 2000) .
Protein turnover
Ets proteins are in general characterized as relatively unstable proteins. The half-life of Ets2 is only 20 min (Fujiwara et al., 1988) . Although the mechanism leading to Ets degradation is not yet characterized, it has been previously demonstrated that Ets1 interacts with Ubc9, an ubiquitin-conjugating enzyme. However, Ets1 stability does not seem to be aected by overexpression of the Ubc9 gene in cells; indeed, cotransfection of Ubc9 with Ets1 in mammalian cells increases the transcription activity of Ets1 (Hahn et al., 1997) . Ubc9 also has been shown to physically interact with TEL and Ets1 (Hahn et al., 1997; Li et al., 2000) through the HLH/Pointed domain. However, it seems that the eect of Ubc9 on Ets transcription activity is not mediated by degrading its target protein. Recently, we have identi®ed an interaction between Ets1 and Uba2 (Li et al., unpublished data) , which has been shown to target proteins for uniquitinization and degradation by SUMO-1 (Dohmen et al., 1995; Okuma et al., 1999) . Further experiments will be required to determine whether Uba2 plays a role in turn-over of Ets1.
Future directions
To date, all the known functional domains of Ets proteins are also associated with interactive protein partners. However, the biological signi®cance of many of these interactions need to be further evaluated (Table 1 , Figure 1 ). It is clear that the Ets family plays an important role in control of physiological condition, development process and neoplastic biological processes. Overlap between speci®c protein ± protein interactions may provide a mechanism to control the diverse functions of Ets family. Such combinatorial control provides a mechanism to ®ne-tune the networks of cellular processes. As an end eector of signaling tranduction pathway, it is critical to determine how extracellular signals are transduced into transcriptional activity (Yordy and Muise-Helmericks, this issue). Future studies will de®ne the precise interactions between Ets proteins, basal transcriptional machinery, co-repressors or co-activators and other bridging proteins that collectively are critical for transcriptional responses. Eorts are needed to continue precise characterization of Ets protein ± partner associations and to determine how these interactions in¯uence target gene selection and transcription activation or repression. It is important to correlate speci®c physical interactions with physiological processes. More sensitive methods need to be developed to allow characterization of transient interactions and for direct assessment of the biological consequences of speci®c interactions. Crystallographic determination of the structure of multiple protein complexes will help in understanding the combinatorial control of transcription. Ultimately, the protein ± protein interface may provide a unique target for intervention. Thus, providing a novel approach for blocking aberrant signaling pathways or reversing the malignant phenotype associated with oncogenic transcription factors.
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